These innovative treatments , including Semaglutide , belong to a group of drugs called GLP-1 mimics . Originally intended for controlling high blood sugar, they work by helping the pancreas to release adequate insulin production and limiting increased blood sugar levels. Furthermore , their ability to promote weight loss has led to increased inter